Raymond James Trust N.A. Acquires 2,317 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Raymond James Trust N.A. grew its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 22.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,556 shares of the company’s stock after acquiring an additional 2,317 shares during the quarter. Raymond James Trust N.A.’s holdings in Stevanato Group were worth $251,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of STVN. Harbor Capital Advisors Inc. grew its stake in Stevanato Group by 109.1% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock worth $163,000 after buying an additional 4,626 shares in the last quarter. Hilltop National Bank grew its position in Stevanato Group by 34.3% in the second quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock worth $81,000 after acquiring an additional 1,122 shares in the last quarter. Schwartz Investment Counsel Inc. increased its stake in Stevanato Group by 12.3% in the second quarter. Schwartz Investment Counsel Inc. now owns 126,281 shares of the company’s stock valued at $2,316,000 after acquiring an additional 13,800 shares during the last quarter. Liontrust Investment Partners LLP purchased a new stake in Stevanato Group during the second quarter valued at about $6,104,000. Finally, Conestoga Capital Advisors LLC lifted its stake in Stevanato Group by 7.3% during the second quarter. Conestoga Capital Advisors LLC now owns 7,275,823 shares of the company’s stock worth $133,439,000 after purchasing an additional 496,930 shares during the last quarter.

Stevanato Group Stock Performance

Shares of NYSE:STVN opened at €20.00 ($21.05) on Thursday. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The company’s fifty day moving average is €19.47 and its 200 day moving average is €19.63. Stevanato Group S.p.A. has a 52 week low of €16.56 ($17.43) and a 52 week high of €34.73 ($36.56).

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm’s quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.16 EPS. As a group, equities research analysts predict that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Citigroup decreased their price objective on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.